Lupin launches generic Renagel
The medication, which is the generic of Genzyme's Renagel, is used to treat hyperphosphatemia in patients with chronic kidney disease.
Lupin is introducing sevelamer hydrochloride tablets in a dosage strength of 800 mg.
The medication, which is the generic of Genzyme's Renagel, is used to treat hyperphosphatemia in patients with chronic kidney disease.
[Read more: Lupin intros authorized generic Duexis]
Sevelamer hydrochloride tablets had a market value of roughly $75 million, according to December 2021 IQVIA data.
The product will be manufactured at Lupin's facility in Nagpur, India.
[Read more: FDA marks competitive generic therapy approval milestone]